These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

625 related items for PubMed ID: 9669097

  • 1. Use of beta-blockers during and after myocardial infarction.
    Aronow WS.
    Compr Ther; 1998; 24(6-7):327-31. PubMed ID: 9669097
    [Abstract] [Full Text] [Related]

  • 2. Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarction.
    Weir R, McMurray JJ.
    Heart; 2005 May; 91 Suppl 2(Suppl 2):ii17-20; discussion ii31, ii43-8. PubMed ID: 15831602
    [Abstract] [Full Text] [Related]

  • 3. Reappraisal of beta-blocker therapy in the acute and chronic post-myocardial infarction period.
    Borrello F, Beahan M, Klein L, Gheorghiade M.
    Rev Cardiovasc Med; 2003 May; 4 Suppl 3():S13-24. PubMed ID: 14564230
    [Abstract] [Full Text] [Related]

  • 4. Review of beta blocker myocardial infarction trials.
    Goldstein S.
    Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III54-7. PubMed ID: 2575021
    [Abstract] [Full Text] [Related]

  • 5. [Beta-adrenergic receptor blockers in clinical practice].
    Czuriga I, Edes I.
    Orv Hetil; 2004 Sep 19; 145(38):1951-60. PubMed ID: 15535106
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Secondary prevention after myocardial infarction: in favor of beta-blockers.
    Lévy S.
    J Cardiovasc Pharmacol; 1990 Sep 19; 16 Suppl 6():S50-4. PubMed ID: 1707116
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Beta-blocker in secondary prevention of cardiovascular disease].
    Sauer G.
    Z Kardiol; 2003 Jan 19; 92(1):24-30. PubMed ID: 12545298
    [Abstract] [Full Text] [Related]

  • 13. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    White HD, Aylward PE, Huang Z, Dalby AJ, Weaver WD, Barvik S, Marin-Neto JA, Murin J, Nordlander RO, van Gilst WH, Zannad F, McMurray JJ, Califf RM, Pfeffer MA, VALIANT Investigators.
    Circulation; 2005 Nov 29; 112(22):3391-9. PubMed ID: 16301343
    [Abstract] [Full Text] [Related]

  • 14. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
    Califf RM, Lokhnygina Y, Velazquez EJ, McMurray JJ, Leimberger JD, Lewis EF, Diaz R, Murin J, Pfeffer MA.
    Am J Cardiol; 2009 Jul 15; 104(2):151-7. PubMed ID: 19576338
    [Abstract] [Full Text] [Related]

  • 15. Heart failure complicating acute myocardial infarction.
    Aronow WS.
    Clin Geriatr Med; 2000 Aug 15; 16(3):535-48. PubMed ID: 10918646
    [Abstract] [Full Text] [Related]

  • 16. Beta-adrenergic blockers in patients with acute myocardial infarction.
    Furberg CD, Byington RP.
    Cardiovasc Clin; 1989 Aug 15; 20(1):235-48. PubMed ID: 2565768
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Up-dating the treatment with beta-blockaders in cardiology].
    Rubio Sanz R, Asin Cardiel E, Rubio Sanz J.
    Rev Clin Esp; 1977 Oct 15; 147(1):103-12. PubMed ID: 22106
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.